ACON Stock Chart & Stats
$2.49
-$0.02(-12.85%)
At close: 4:00 PM EST
$2.49
-$0.02(-12.85%)
Day’s Range― - ―
52-Week Range$1.95 - $12.03
Previous Close$0.14
Volume6.36M
Average Volume (3M)43.03K
Market Cap
$6.74M
Enterprise Value-$17.35T
Total Cash (Recent Filing)$16.29M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,882,371
10 Day Avg. Volume33,284
30 Day Avg. Volume43,035
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.19
Price to Sales (P/S)32.32
P/FCF Ratio-0.34
Enterprise Value/Market Cap-2.57M
Enterprise Value/Revenue-207.07M
Enterprise Value/Gross Profit406.38M
Enterprise Value/Ebitda1.94M
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aclarion, Inc. News
ACON FAQ
What was Aclarion, Inc.’s price range in the past 12 months?
Aclarion, Inc. lowest stock price was $1.95 and its highest was $12.03 in the past 12 months.
What is Aclarion, Inc.’s market cap?
Aclarion, Inc.’s market cap is $6.74M.
When is Aclarion, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aclarion, Inc.’s earnings last quarter?
Currently, no data Available
Is Aclarion, Inc. overvalued?
According to Wall Street analysts Aclarion, Inc.’s price is currently Overvalued.
Does Aclarion, Inc. pay dividends?
Aclarion, Inc. does not currently pay dividends.
What is Aclarion, Inc.’s EPS estimate?
Aclarion, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aclarion, Inc. have?
Aclarion, Inc. has 2,882,371 shares outstanding.
What happened to Aclarion, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aclarion, Inc.?
Currently, no hedge funds are holding shares in ACON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aclarion, Inc.
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.
Technical Analysis
Ownership Overview
16.41% Insiders
0.62% Mutual Funds
0.68% Other Institutional Investors
82.06% Public Companies and
Individual Investors